1. Mitomycin C in the treatment of early triple-negative locally advanced BRCA-associated breast cancer
    D. A. Enaldieva et al, 2024, Medical alphabet CrossRef
  2. PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
    Maddison Rose et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
  3. Efficacy of Cold Atmospheric Plasma vs. Chemotherapy in Triple-Negative Breast Cancer: A Systematic Review
    Catarina Almeida-Ferreira et al, 2024, International Journal of Molecular Sciences CrossRef
  4. Clinical Characteristics in Patients with Triple Negative Breast Cancer
    Janet Yeh et al, 2017, International Journal of Breast Cancer CrossRef
  5. PARP1 proximity proteomics reveals interaction partners at stressed replication forks
    Thorsten Mosler et al, 2022, Nucleic Acids Research CrossRef
  6. Breast cancer in global health: beyond diversity and inequality
    Lin Liu et al, 2020, International Journal of Surgery: Global Health CrossRef
  7. Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel
    Madhavi Gangapuram et al, 2021, International Journal of Molecular Sciences CrossRef
  8. Comparative analysis of the effectiveness of neoadjuvant systemic therapy and primary surgical treatment of patients with BRCA-associated triple-negative T1 breast cancer
    Diana A. Enaldieva et al, 2023, HERALD of North-Western State Medical University named after I.I. Mechnikov CrossRef
  9. Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine
    Anastasiia Samusieva et al, 2022, Breast Cancer Research and Treatment CrossRef
  10. The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer after neoadjuvant treatment: a single institution experience
    D. A. Enaldieva et al, 2023, Tumors of female reproductive system CrossRef
  11. The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database
    Maiko Okano et al, 2021, Journal of Human Genetics CrossRef
  12. Lymph node status as a prognostic factor in BRCA-positive breast cancer
    Jeeyeon Lee et al, 2017, Journal of Surgical Research CrossRef
  13. Heat Shock Proteins in Triple-Negative Breast Cancer (TNBC) Treatment
    Punit Kaur et al, 2015, Heat Shock Protein-Based Therapies CrossRef
  14. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients
    Muhammad Usman Rashid et al, 2016, BMC Cancer CrossRef